Get started
Author

David Leduc

Observed names: D LeDuc, D. LeDuc, D. Leduc, David LeDuc, Leduc, David
Observed institution: Go2 for Lung Cancer
OpenAlex ID: A5001829945
Abstract 4744: A prospective biospecimen collection study from patients with EGFR mutant tumors
2019 · Ivy B. Elkins, Jill Feldman, et al. · Experimental and Molecular Therapeutics · 7
Patient reported toxicities: Development and validation of patient-reported symptom measure for lung cancer patients receiving immunotherapy.
2019 · Sandra S. Shaw, Heather S.L. Jim, et al. · Journal of Clinical Oncology · 4
OA10.02 Oncogene-Driven Patient Groups: A New Era For Research Partnerships
2018 · J. Freeman-Daily, I. Elkins, et al. · Journal of Thoracic Oncology · 3
PDF
P2.16-23 Rates of Support and Care Offerings Among Patients in an Advocacy Organization Sponsored Lung Cancer Patient Registry
2019 · A. Ciupek, R. Acharya, et al. · Journal of Thoracic Oncology · 1
PDF
Abstract 4744: A prospective biospecimen collection study from patients with EGFR mutant tumors
2019 · Ivy B. Elkins, Jill Feldman, et al. · Cancer Research · 1
Intérêts, freins et leviers pour optimiser le raisonnement de la fertilisation des cultures en France et en Europe
2025 · Degan, Francesca, Jordan‐meille, Lionel, et al. · Agronomie environnement & sociétés
PDF
A novel approach to capture patient-reported toxicities of immunotherapy for non-small cell lung cancer using a foundation-sponsored patient registry.
2018 · Heather S.L. Jim, Sandra S. Shaw, et al. · Journal of Clinical Oncology
MS 27.03 Lung Cancer Registry: Using Patient Data to Improve Outcomes and Quality of Life
2017 · D. LeDuc · Journal of Thoracic Oncology
PA01.03 Establishing a Paradigm for High Quality Lung Cancer Treatment
2017 · David Leduc · Journal of Thoracic Oncology
PDF
Networks to give "local" review of first-year renal transplant outcomes.
1999 · D Carlson, D LeDuc, et al. · PubMed
Works count: 10
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type